Multiple myeloma (MM) is one of the three major malignancies of the hematological system
in middle‑aged and older individuals. The incidence of MM increases with age and due to its …

Multiple myeloma (MM) is the second most common hematooncological disease of
malignant plasma cells in the bone marrow. While new treatment brought unprecedented …

Multiple myeloma (MM) is still an incurable disease, and its pathogenesis involves
cytogenetics and epigenetics. In recent years, the roles of long non‐coding RNAs (lncRNAs) …

Simple Summary Multiple myeloma (MM), the second most common hematological
neoplasm, is still considered an incurable disease. Long non-coding RNAs (lncRNAs) …

Multiple myeloma (MM) is an incurable disease caused by the malignant proliferation of
bone marrow plasma cells, whose pathogenesis remains largely unknown. Although a large …

Transcripts longer than 200 nucleotides that are not translated into proteins are known as
long non-coding RNAs, or lncRNAs. Now, they are becoming more significant as important …

Multiple myeloma (MM), a type of malignant tumor, is characterized by dysplasia of clonal
plasma cells in the bone marrow. People with MM will have damaged organs or tissues due …

Abstract Background Long noncoding RNAs (lncRNAs) are involved in a wide range of
biological processes in tumorigenesis. However, the role of lncRNA expression in the …

Simple Summary Multiple myeloma (MM) is an aggressive hematological neoplasia caused
by the uncontrolled proliferation of aberrant plasmacells. Neoplastic transformation and …

Aims Multiple myeloma (MM) is an incurable hematological cancer with a higher rate of
relapse. Alterations in the function of long non-coding RNAs (lncRNAs) promote the …